Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers T > Headlines for Talecris Biotherapeutics Inc. > News item |
S&P affirms Talecris
Standard & Poor's said it revised the outlook on Talecris Biotherapeutics Inc. to stable from negative and affirmed its B corporate credit rating.
"The action reflects Talecris' improving operating performance and the removal of plasma supply constraints - due to the company's successful efforts in developing its plasma collection platform and a supply agreement with CSL - that previously limited its production volumes," S&P analyst Arthur Wong said in a statement.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.